Newsroom
September 8, 2020
Although it’s not a cure for ALS, an oral drug slowed patients’ rate of functional decline in a clinical trial that included five patients at UT Health San Antonio. If the finding is repeated in larger trials, the drug could give families more time with their loved ones who have ALS. The New England Journal […]
August 25, 2020
In the war on cancer and other diseases including COVID-19, old drugs approved for other conditions are being studied for new purposes. It’s a strategy that will now be tested in Alzheimer’s disease with a drug called rapamycin. A $2 million grant will enable a clinical trial in which 40 individuals with mild cognitive impairment […]
August 20, 2020
The Cancer Prevention and Research Institute of Texas awarded more than $10.3 million to the Mays Cancer Center.
August 3, 2020
Amy Garrett, PhD, assistant professor of radiology and psychiatry and director of the neuroimaging core for the Department of Psychiatry, was interviewed as an outside expert to provide context in this story about a new study that suggests experiencing adversity early in life is likely to make children reach puberty more quickly, increase cellular aging […]
August 3, 2020
Structures called primary cilia – which act like TV antennas for cells to detect signals – are present in fewer numbers in mice born with Fragile X syndrome, according to researchers.
July 30, 2020
Structures called primary cilia – which act like TV antennas for cells to detect signals – are present in fewer numbers in mice born with Fragile X syndrome, according to researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio). Study results were published July 30 in the journal […]
